Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyPeter L. Greenberg, Courtney Smith, H. Joachim Deeg et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 297
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Shin Mineishi, Hiromi Tobai et al.|Blood|2011Cited by 57
Myelodysplastic Syndromes, Version 2.2015Peter L. Greenberg, Courtney Smith, Richard M. Stone et al.|Journal of the National Comprehensive Cancer Network|2015Cited by 54
Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AMLShin Mineishi, John E. Levine, Hiromi Tobai et al.|Blood|2010Cited by 15